Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Arachidonate 5-lipoxygenase-activating protein (FLAP) is a membrane protein essential for leukotriene biosynthesis. It activates and anchors arachidonate 5-lipoxygenase (ALOX5), facilitating the conversion of arachidonic acid into leukotrienes. As leukotrienes are potent mediators of inflammation, FLAP is a therapeutic target for inflammatory diseases.
Inhibition of FLAP prevents the interaction between FLAP and ALOX5, blocking leukotriene synthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Arachidonate 5-lipoxygenase-activating protein (FLAP).